Current Size: 100%


Current collaborations of group LK 
The group of LK holds long term international and national collaborations. It was essential for joint publications, but also successful grant money attraction:


Zoran Culig, Medical University Innsbruck, Urology Department, on Stat3 signaling and invasion in prostate cancer.

Thomas Decker, MFPL Vienna IFNAR in IBD

Uli Jäger, MUW, Internal Medicine Department I, Role of PDGFR in NPM-ALK lymphomagenesis.

Helmut Klocker, Medical University Innsbruck, Urology Department, on the role of IGF-1 axis and MID-1 in mouse and human prostate cancer.

Hannes Neuwirth, Medical University Innsbruck, Internal Medicine Department IV, on Stat3 signaling and invasion in renal carcinogenesis.

Mathias Müller, University of Veterinary Medicine, Vienna, Tyk2 in IBD.

Josef Penninger, IMBA Vienna, on the role of RANKL in MMTV induced breast Cancer tumor induction.

Thomas Rülicke, University of Veterinary Medicine, Vienna, Phenotyping of heart disease in transgenic mouse models.

Maria Sibilia, CCC, MUW, EGFR in animal models for colitis.

Christian Seiser, Max F. Perutz Laboratories, Medical University of Vienna, Vienna Biocenter, on HDAC regulated stem cell differentiation and tumorigenesis

Veronika Sexl, University of Veterinary Medicine, Vienna, CDK6 in NPM-ALK transgenic mice.

Peter Valent, MUW, Internal Medicine Department I, Imatinib treatment of NPM-ALK transgenic mice.


Sebastian Bauer, Institute of Cancer Research of the Internal Medicine Department, University Duisburg-Essen, Germany on GIST mutations of c-KIT in human GIST tumor formation.

Fabrice Gouilleux, University Picardie Jules Verne, INSERM 0351, Amiens, France, on GIST and activated forms of Stat3.

Greg Hannon, Cold Spring Harbor (CSH) Laboratory, NY, on the role of miRNA in umbilical cordblood stemcell differentiation.

Markus Heim, Biomedical Department, University Hospital Basel, Switzerland, on liver cancer.

Konrad Hochedlinger, Harvard Stem Cell Institute, Cambridge, MA, U.S.A., on stem cell induction using viral vectors.

Giorgio Inghirami, Friedrich Schiller University, Jena, Germany, Center for Experimental Research and Medical Studies, University of Torino, Italy on the role of AP-1 in NPM-ALK induced human- and mouse lymphomagenesis.

Colin McGuckin, Cell Therapy Research Institute (CTI), University of Lyon, on MSC differentiation and regulation of adult stem cell development as well as Jak/Stat pathway in stem cell differentiation and tumorigenesis: Collaboration in the Novussanguis Consortium.

Mark Parthun, Ohio State University, Columbus, Characterisation of HAT-/-.

Mariusz Ratajczak, University of Luiseville, Stem cell Institute at James Brown Cancer Center, KY, USA, on cancer stem cell induced rhabdomyosarcoma development.

Stefan Rose-John, University of Kiel, Germany, on the role of IL-6 and Stat3 in Prostate cancer.

Raffaella Sordella, Cold Sprin Harbor Laboratories (CSHL), on the role of IL-6 in lung carcinogenesis.

William Tse, West Virginia University School of Medicine, Morgantown, USA, AF1q in breast cancer metastasis.

Jan Tuckermann, University of Ulm, on transgenic Stat5 and GR mice in inflammatory diseases.

Suzanne Turner, University of Cambridge UK, Tumour–stroma interactions and stem cell pathology in ALC


Visit and talk of Lukas Kenner at the CNIO/Madrid and University of Madrid 2009. From left to right: Mariano Barbacid (Director, CNIO), Elena Postigo-Solana (Univ. Madrid), Erwin F. Wagner (Debuty Director CNIO) and Lukas Kenner (LBI-CR) at dinner in downtown Madrid.


Visiting scientist Arne Östman, Karolinska Institute and Lukas Kenner discussing joint projects in the Cafè Central, Vienna.


Visiting scientist Markus Heim, Department for Biomedicine, University Basel enyoing a glass of vine together with Lukas Kenner, after his talk at the LBI-CR in the Heurigen “Feuerwehr Wagner” in Grinzing, Vienna.

Visit and lecture at the CSH Laboratory NY: Greg Hannon and Lukas Kenner talking about the role of miRNAs in tumor development in the CSH cafeteria.

Research Groups: